Adam Vandervoort - Teladoc Health Chief Sec
| T2DH34 Stock | BRL 2.40 0.03 1.27% |
Insider
Adam Vandervoort is Chief Sec of Teladoc Health
| Age | 48 |
| Phone | 203 635 2002 |
| Web | https://www.teladochealth.com |
Adam Vandervoort Latest Insider Activity
Tracking and analyzing the buying and selling activities of Adam Vandervoort against Teladoc Health stock is an integral part of due diligence when investing in Teladoc Health. Adam Vandervoort insider activity provides valuable insight into whether Teladoc Health is net buyers or sellers over its current business cycle. Note, Teladoc Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Teladoc Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Adam Vandervoort over six months ago Acquisition by Adam Vandervoort of 64200 shares of Teladoc subject to Rule 16b-3 |
Teladoc Health Management Efficiency
The company has return on total asset (ROA) of (0.0113) % which means that it has lost $0.0113 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8948) %, meaning that it generated substantial loss on money invested by shareholders. Teladoc Health's management efficiency ratios could be used to measure how well Teladoc Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Luciano Comin | British American Tobacco | 53 | |
| Gary Norcross | Fidelity National Information | 57 | |
| Ron Martino | NXP Semiconductors NV | N/A | |
| Lars Reger | NXP Semiconductors NV | N/A | |
| Brian Vereb | Bread Financial Holdings | N/A | |
| William Betz | NXP Semiconductors NV | 45 | |
| Christine Pambianchi | Verizon Communications | 50 | |
| Christopher Jensen | NXP Semiconductors NV | 54 | |
| Tamara Erwin | Verizon Communications | 58 | |
| Martin Boyd | Fidelity National Information | 60 | |
| Jeff Palmer | NXP Semiconductors NV | N/A | |
| Mike Sharman | Beyond Meat | N/A | |
| Jack Bowles | British American Tobacco | 59 | |
| Nidhi Tuli | Fidelity National Information | N/A | |
| Erik Hoag | Fidelity National Information | N/A | |
| Kurt Sievers | NXP Semiconductors NV | 54 | |
| Andrew Micallef | NXP Semiconductors NV | 58 | |
| Joseph III | Bread Financial Holdings | 61 | |
| Hae Kim | British American Tobacco | 49 | |
| Matthew Koder | Bank of America | 51 | |
| Roxanne Austin | Verizon Communications | 58 | |
Management Performance
| Return On Equity | -0.89 | |||
| Return On Asset | -0.0113 |
Teladoc Health Leadership Team
Elected by the shareholders, the Teladoc Health's board of directors comprises two types of representatives: Teladoc Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Teladoc. The board's role is to monitor Teladoc Health's management team and ensure that shareholders' interests are well served. Teladoc Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Teladoc Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mike Waters, Chief Officer | ||
| Mala Murthy, Chief Officer | ||
| Adam Vandervoort, Chief Sec | ||
| Andrew Turitz, Sr Devel | ||
| George Brooks, CoFounder | ||
| Richard Napolitano, Chief VP | ||
| CPA CFA, VP Relations | ||
| Jason Gorevic, CEO Director | ||
| Courtney McLeod, Director Communication | ||
| Claus Jensen, Chief Officer |
Teladoc Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Teladoc Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.0113 | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 27.98 B | |||
| Shares Outstanding | 161.93 M | |||
| Price To Book | 0.03 X | |||
| Price To Sales | 10.12 X | |||
| Revenue | 2.03 B | |||
| Gross Profit | 1.38 B | |||
| EBITDA | (84.67 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Teladoc Stock
Teladoc Health financial ratios help investors to determine whether Teladoc Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teladoc with respect to the benefits of owning Teladoc Health security.